Domov › Ateroskleroza › Pennsylvania
Klinične študije za Ateroskleroza v Pennsylvania
11 študij za Ateroskleroza išče udeležence na lokacijah v Pennsylvania.
Mesta v Pennsylvania
Uradno besedilo študije (angleško)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Preferred Primary Care Physicians, Inc, Pittsburgh
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Lehigh Valley Health Network, Allentown
- Capital Area Research, LLC, Camp Hill
- Altoona Center For Clinical Research, Duncansville
- in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Heritage Valley Multispecialty Group Inc, Beaver
- Capital Area Research LLC, Camp Hill
- Abington Medical Specialists, Horsham
Vključevanje udeležencevFaza 3
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Capital Area Research, LLC - Camp Hill, Camp Hill
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07521007A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Heart and Vascular Research at WellSpan Health, York
Vključevanje udeležencevFaza 3
Starost 45–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07613294Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Camp Hill
- Research Site, Horsham
- Research Site, Philadelphia
- in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Care Access Research, Easton
- TCV Clinical Studies, Linwood
Vključevanje udeležencevFaza 3
Starost 18–100 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06875973MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Vključevanje udeležencevFaza 3
Starost 35–89 · Vsi spoli · Posodobljeno 21. apr. 2026 · NCT05132439How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 25. mar. 2026 · NCT07121010Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.